Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Merck updates development of higher dose Zocor

May 21, 1997

Positive phase II/III results for Cortecs' Macritonin

May 20, 1997

FDA advisory committee recommends Roche's Xenical for weight loss

May 15, 1997

FDA approves Columbia's Crinone

May 15, 1997

GH secretagogues disclosed by Merck & Co.

May 14, 1997

Osiris Therapeutics obtains U.S. patent for mesenchymal stem cell gene therapy

May 13, 1997

Osaterone enhances bone formation in ovariectomized rats

May 12, 1997

Effects of L-692429 in obese and nonobese young men

May 12, 1997

Procter & Gamble and Hoechst Marion Roussel to comarket Actonel

May 12, 1997

Prodrugs of calcitriol disclosed by Wisconsin Alumni Research Foundation

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...